APA

DiNubile M. J., Chow J. W., Satishchandran V., Polis A., Motyl M. R., Abramson M. A. & Teppler H. (20050919). Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections. : Antimicrobial agents and chemotherapy.

Chicago

DiNubile Mark J, Chow Joseph W, Satishchandran Vilas, Polis Adam, Motyl Mary R, Abramson Murray A and Teppler Hedy. 20050919. Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections. : Antimicrobial agents and chemotherapy.

Harvard

DiNubile M. J., Chow J. W., Satishchandran V., Polis A., Motyl M. R., Abramson M. A. and Teppler H. (20050919). Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections. : Antimicrobial agents and chemotherapy.

MLA

DiNubile Mark J, Chow Joseph W, Satishchandran Vilas, Polis Adam, Motyl Mary R, Abramson Murray A and Teppler Hedy. Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections. : Antimicrobial agents and chemotherapy. 20050919.